Literature DB >> 26093735

Evaluation of Infectious Complications in the First Year After Kidney Transplantation.

A Yalci1, Z K Celebi2, B Ozbas3, O L Sengezer4, H Unal4, K O Memikoğlu4, S Sengul2, A Tuzuner5, K Keven2.   

Abstract

Kidney transplantation (KT) is the best available therapy for patients with end-stage renal disease. Infectious complications are a common cause of morbidity and mortality. In this study, we evaluated the risk factors and outcomes of infectious complications in the first year after transplantation. This is a retrospective and observational study of kidney transplant recipients at Ankara University's Ibni Sina Hospital between January 2009 and August 2013. A total of 206 kidney transplant recipients were evaluated. In 129 patients, 298 infectious episodes occurred: 55 (26.7%) had 1; 33 (16%) 2; 19 (9.2%) 3; 7 (3.4%) 4; and 15 (7.3%) had 5 or more infectious episodes. The most common bacterial infection was urinary tract infection (128, 42.9%). Only 4 urinary tract infection episodes (3.1%) were associated with bacteriemia. Seventeen patients (5.7%) had bacteremia. Viral infections after transplantation were CMV infection (10.1%), BK virus infection (5.7%), and zona zoster (1.1%). Deceased donor kidney transplantation was the independent risk factor. Mean follow-up period was 66 months and was the same for the patients with and without infections. There was no significant difference in 5-year survival and creatinine levels at the last follow-up (logrank P = .409). Infections are the second most common cause of mortality in KT patients. The successful treatment of these complications and effective prophylaxis may decrease these complications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26093735     DOI: 10.1016/j.transproceed.2015.04.056

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

1.  Oral shedding of human herpesviruses in renal transplant recipients.

Authors:  Dmitry José de Santana Sarmento; Tânia Regina Tozetto-Mendoza; Laura Masami Sumita; Ligia Camara Pierroti; Débora Pallos; Rubens Caliento; Michelle Palmieri; Victor Adriano de Oliveira Martins; Marina Gallottini; Claudio Sergio Pannuti; Paulo Henrique Braz-Silva
Journal:  Clin Oral Investig       Date:  2017-07-01       Impact factor: 3.573

2.  Antibiotic therapy in case of positive cultures of kidney transplant preservation fluid: a nationwide survey of prescribing practices.

Authors:  N Le Berre; M Ladrière; A Corbel; T Remen; L Durin; L Frimat; N Thilly; C Pulcini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-04       Impact factor: 3.267

3.  Evaluation of early and late-term infections after renal transplantation: Clinical experiences of Sanko University Medical Faculty Transplantation Center.

Authors:  Hatem Kazımoğlu; Rezan Harman; Mehmet Necmettin Mercimek; Mehmet Dokur; Erdal Uysal
Journal:  Turk J Urol       Date:  2018-07-27

4.  Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia.

Authors:  Ilona Baraniak; Barbara Kropff; Gary R McLean; Sylvie Pichon; Fabienne Piras-Douce; Richard S B Milne; Colette Smith; Michael Mach; Paul D Griffiths; Matthew B Reeves
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

5.  Mesangial cells, specialized renal pericytes and cytomegalovirus infectivity: Implications for HCMV pathology in the glomerular vascular unit and post-transplant renal disease.

Authors:  Waldemar Popik; Hernan Correa; Atanu Khatua; David M Aronoff; Donald J Alcendor
Journal:  J Transl Sci       Date:  2018-05-24

6.  Risk of relapse of multiple myeloma following kidney transplantation.

Authors:  Sapna Shah; Maria Ibrahim; Michael Delaney; Steve Schey; Ceri Bygrave; Matthew Streetly; Reuben Benjamin
Journal:  Clin Kidney J       Date:  2019-01-25

7.  Epidemiology, risk factors, and clinical impact of early post-transplant infection in older kidney transplant recipients: the Korean organ transplantation registry study.

Authors:  Jin Sug Kim; Kyung Hwan Jeong; Dong Won Lee; Sam Yeol Lee; Sang Ho Lee; Jaeseok Yang; Curie Ahn; Hyeon Seok Hwang
Journal:  BMC Geriatr       Date:  2020-12-02       Impact factor: 3.921

8.  Distribution and Antibiotic Susceptibility Pattern of Multidrug-Resistant Bacteria and Risk Factors Among Kidney Transplantation Recipients with Infections Over 13 Years: A Retrospective Study.

Authors:  Liying Gong; Luwei Zhang; Xiaoli Liu; Bekzod Odilov; Shengnan Li; Zhao Hu; Xiaoyan Xiao
Journal:  Infect Drug Resist       Date:  2021-12-24       Impact factor: 4.003

Review 9.  BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection.

Authors:  Darlene Vigil; Nikifor K Konstantinov; Marc Barry; Antonia M Harford; Karen S Servilla; Young Ho Kim; Yijuan Sun; Kavitha Ganta; Antonios H Tzamaloukas
Journal:  World J Transplant       Date:  2016-09-24

10.  Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection.

Authors:  Matthew Magruder; Adam N Sholi; Catherine Gong; Lisa Zhang; Emmanuel Edusei; Jennifer Huang; Shady Albakry; Michael J Satlin; Lars F Westblade; Carl Crawford; Darshana M Dadhania; Michelle Lubetzky; Ying Taur; Eric Littman; Lilan Ling; Philip Burnham; Iwijn De Vlaminck; Eric Pamer; Manikkam Suthanthiran; John Richard Lee
Journal:  Nat Commun       Date:  2019-12-04       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.